← All trials
NCT04333537
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 18, 2020
- Primary completion
- May 18, 2031
- Completion date
- May 18, 2036
- First posted
- Apr 3, 2020
- Last posted
- Apr 20, 2020
- Enrollment
- 618
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- NRG OncologyLead sponsor
- National Cancer Institute (NCI)Collaborator
- NRG OncologyOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.